INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS)

$9.9 -1.4 (-12.3894%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 75

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) News Sources

Innovent Biologics (SEHK:1801) Stock Still Looks Below Fair Value As Shares Rose 153%

29-09-2026

yahoo.com

Top China Biopharma Stocks to Watch, According to Bernstein

30-09-2026

yahoo.com

Innovent Announces Phase 3 RESTORE-3 Study of SYCUME® (Teprotumumab N01 Injection) Met Primary Endpoint in Inactive Thyroid Eye Disease

09-10-2026

yahoo.com

2026 ESMO LBA | Innovent Announces International Phase 3 Study of Arcotatug Tavatecan (CLDN18.2-ADC) in Gastric Cancer Met Dual Primary Endpoints of PFS and OS

23-10-2026

yahoo.com

Phase 3 Cancer Trial Win Could Be A Game Changer For Innovent Biologics Stock

24-10-2026

yahoo.com

2026 ESMO | Innovent Presented Phase 1 Study Data for IBI3001, a First-in-Class EGFR/B7H3 Bispecific ADC

25-10-2026

yahoo.com

2026 ESMO | Innovent Announcement Phase 2 Data Presentation for IBI354 (HER2 ADC) In First-line Treatment of Breast Cancer

25-10-2026

yahoo.com

2026 ESMO | Innovent Presents Multiple Clinical Data Updates for IBI363/TAK-928, a PD-1/Alpha-Biased IL-2 Bispecific Fusion Protein

26-10-2026

yahoo.com

Innovent Announces NMPA Acceptance of a New Indication Application of Sintilimab for the Treatment of Advanced Melanoma

26-10-2026

yahoo.com

Altruist Biologics' Integrated CMC Platform Supports NMPA Acceptance of NDA for Localized Manufacturing of Multinational Client's Biologic

29-10-2026

yahoo.com

INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) Sentiment Trend

0 25 50 75 100 70 93 70 69 83 76 82 83 63 66 29-09-2026 30-09-2026 09-10-2026 23-10-2026 24-10-2026 25-10-2026 26-10-2026 29-10-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) FAQs

toggle

What is the current price of INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS)?

The current price of INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) is $9.9.


toggle

INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) absolute price change since previous trading day?

The absolute price change of INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) since the previous trading day is $-1.4.


toggle

INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) percentage price change since previous trading day?

The percentage price change of INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) since the previous trading day is -12.3894%.


toggle

What is the most recent average sentiment score for INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS)?

The most recent average sentiment score for INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) is 75 out of 100.


toggle

What is the most recent average sentiment for INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS)?

The most recent sentiment for INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS) is .


SEC-8K** Filing Available For INNOVENT BIOLOGICS INC (IVBXF:OTCMKTS)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.